Trial Profile
A Randomized, Open Label, Repeated-dose, Crossover Study to Investigate the Pharmacokinetic Drug Interactions and Safety Among D326, D337 and CKD-828 in Healthy Subjects
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 05 Oct 2020
Price :
$35
*
At a glance
- Drugs Levamlodipine/telmisartan (Primary)
- Indications Dyslipidaemias; Hypertension
- Focus Pharmacokinetics
- Sponsors Chong Kun Dang
- 12 Nov 2018 New trial record